Publication & Citation Trends
Publications
0 total
A phase II study of the multitargeted kinase inhibitor lenvatinib in patients with advanced BRAF wild-type melanoma.
Cited by 13
Semantic Scholar
Analysis of plasma biomarker and tumor genetic alterations from a phase II trial of lenvatinib in patients with advanced endometrial cancer.
Cited by 9
Semantic Scholar
A phase II trial of lenvatinib in patients with advanced or recurrent endometrial cancer: Angiopoietin-2 as a predictive marker for clinical outcomes.
Cited by 47
Semantic Scholar
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Cited by 961
Semantic Scholar
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. OA
Cited by 263
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(4)
Microtubule and mitosis dynamics
(3)
HER2/EGFR in Cancer Research
(3)
Angiogenesis and VEGF in Cancer
(2)
Endometrial and Cervical Cancer Treatments
(2)
Affiliations
SUNY Upstate Medical University
Cornell University
Texas Oncology
Harrington Cancer Center
Eisai (United States)